Cart
sales@molnova.com
2′,2′-Difluorodeoxyuridine
CAS No. 114248-23-6
2′,2′-Difluorodeoxyuridine( —— )
Catalog No. M35912 CAS No. 114248-23-6
2′,2′-Difluorodeoxyuridine (dFdU), the major metabolite of Gemcitabine, exhibits anticancer and antitumor activities, shows radiosensitization under hypoxic conditions, and can be used to study pancreatic cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 32 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 71 | In Stock |
|
| 50MG | 100 | In Stock |
|
| 100MG | 147 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2′,2′-Difluorodeoxyuridine
-
NoteResearch use only, not for human use.
-
Brief Description2′,2′-Difluorodeoxyuridine (dFdU), the major metabolite of Gemcitabine, exhibits anticancer and antitumor activities, shows radiosensitization under hypoxic conditions, and can be used to study pancreatic cancer.
-
Description2′,2′-Difluorodeoxyuridine (dFdU) is the main metabolite of Gemcitabine (HY-17026). 2′,2′-Difluorodeoxyuridine causes a concentration- and schedule- dependent radiosensitising effect in vitro.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorDrug Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114248-23-6
-
Formula Weight264.18
-
Molecular FormulaC9H10F2N2O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (473.16 mM; Ultrasonic ) H2O : 100 mg/mL (378.53 mM; Ultrasonic)
-
SMILESOC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)C(F)(F)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pauwels B, et al. The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro. Cancer Chemother Pharmacol. 2006 Aug;58(2):219-28.?
molnova catalog
related products
-
Doripenem Hydrate
Doripenem monohydrate is a new member of the carbapenem class of beta-lactam?antibiotics?with broad-spectrum coverage of Gram-positive, Gram-negative and anaerobic pathogens.
-
Sequoiaflavone
Sequoiaflavone is a biflavone isolated from Ginkgo biloba.
-
MYLS22
MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
